SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001104659-12-063188
Filing Date
2012-09-13
Accepted
2012-09-13 08:05:16
Documents
6
Period of Report
2012-09-12
Items
Item 1.01: Entry into a Material Definitive Agreement
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K a12-21095_18k.htm 8-K 42695
2 EX-1.1 a12-21095_1ex1d1.htm EX-1.1 205844
3 EX-5.1 a12-21095_1ex5d1.htm EX-5.1 11640
4 EX-99.1 a12-21095_1ex99d1.htm EX-99.1 12169
5 GRAPHIC g210951mmi001.jpg GRAPHIC 4227
6 GRAPHIC g210951kgi001.jpg GRAPHIC 2234
  Complete submission text file 0001104659-12-063188.txt   282709
Mailing Address 5001 SOUTH MIAMI BOULEVARD SUITE 300 DURHAM NC 27703
Business Address 5001 SOUTH MIAMI BOULEVARD SUITE 300 DURHAM NC 27703 919 474 0020
TRANZYME INC (Filer) CIK: 0001274644 (see all company filings)

IRS No.: 631192270 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-35119 | Film No.: 121089062
SIC: 2834 Pharmaceutical Preparations